228 research outputs found

    Evaluation of modelling approaches for predicting the spatial distribution of soil organic carbon stocks at the national scale

    Get PDF
    Soil organic carbon (SOC) plays a major role in the global carbon budget. It can act as a source or a sink of atmospheric carbon, thereby possibly influencing the course of climate change. Improving the tools that model the spatial distributions of SOC stocks at national scales is a priority, both for monitoring changes in SOC and as an input for global carbon cycles studies. In this paper, we compare and evaluate two recent and promising modelling approaches. First, we considered several increasingly complex boosted regression trees (BRT), a convenient and efficient multiple regression model from the statistical learning field. Further, we considered a robust geostatistical approach coupled to the BRT models. Testing the different approaches was performed on the dataset from the French Soil Monitoring Network, with a consistent cross-validation procedure. We showed that when a limited number of predictors were included in the BRT model, the standalone BRT predictions were significantly improved by robust geostatistical modelling of the residuals. However, when data for several SOC drivers were included, the standalone BRT model predictions were not significantly improved by geostatistical modelling. Therefore, in this latter situation, the BRT predictions might be considered adequate without the need for geostatistical modelling, provided that i) care is exercised in model fitting and validating, and ii) the dataset does not allow for modelling of local spatial autocorrelations, as is the case for many national systematic sampling schemes

    Estimation de stocks de carbone organique des sols à différentes échelles d'espace et de temps

    Get PDF
    National audienceCet article traite de l’estimation des stocks de carbone organique des sols Ă  diffĂ©rentes Ă©chelles d’espace et de temps. Dans une premiĂšre partie nous passons en revue les principales Ă©chelles de variabilitĂ© des stocks de carbone des sols et nous en tirons des recommandations quant aux techniques Ă  utiliser pour leur estimation et des considĂ©rations sur les incertitudes associĂ©es Ă  ces estimations. Nous analysons ensuite les consĂ©quences de cette variabilitĂ© sur la faisabilitĂ© de la dĂ©tection de changements au cours du temps et sur l’optimisation des dispositifs de surveillance in situ. Dans une derniĂšre partie nous comparons diffĂ©rentes techniques analytiques et nous dĂ©veloppons l’apport potentiel que pourraient reprĂ©senter les techniques de spectromĂ©trie infra-rouge

    Fertilité des sols: conclusions du rapport sur l'état des sols de France

    Get PDF
    Les sols constituent une ressource naturelle non renouvelable. Leurs usages et leur devenir reprĂ©sentent un enjeu collectif majeur, tant pour les activitĂ©s agricoles ou sylvicoles que pour la prĂ©servation de la qualitĂ© de notre environnement. AprĂšs dix ans de travaux, le Groupement d’IntĂ©rĂȘt Scientifique sur les sols, le Gis Sol, a dressĂ© le premier bilan scientifiquement quantifiĂ© de l’état des sols de France mĂ©tropolitaine et d’Outre-mer dans un rapport sur l’état des sols de France publiĂ© en 2011. Ce rapport relĂšve des points positifs mais Ă©galement un certain nombre de prĂ©occupations du point de vue de la fertilitĂ©. Les sols agricoles ne prĂ©sentent pas d’évolution mesurable de leur aciditĂ©, ce quiindique une bonne gestion du pH Ă  l’échelle nationale. Le rapport fait en revanche Ă©tat de teneurs en phosphore relativement faibles pour de nombreux sols, et Ă  l’inverse de situations d’excĂ©dents trĂšs prĂ©occupantes en raison de son impact sur la qualitĂ© des eaux et l’eutrophisation des milieux. Il pose ainsi la question de la durabilitĂ© Ă  long terme du systĂšme agricole actuel et celle d’une meilleure valorisation des effluents d’élevage. D’assez nombreuses situations pourraient Ă©galement ĂȘtre susceptibles de provoquer des carences en oligo-Ă©lĂ©ments pour des cultures exigeantes. Enfin, une inquiĂ©tude majeure concerne la progression de l’artificialisation des sols, qui s’est accĂ©lĂ©rĂ©e durant la derniĂšre dĂ©cennie et occasionne des pertes importantes de sols agricoles.Soils are a non-renewable, natural resource. Their uses and their future represent, therefore, a collective issue for agricultural and forestry production, as well as for the preservation of our environment. After ten years of work, the “Groupement d’intĂ©rĂȘt scientifique sur les sols”, the Gis Sol (Soils Scientific Interest Group) has presented the first appraisal of soil quality in mainland France and its overseas territories in a report on the state of the soils in France published in 2011. This appraisal shows evidence for positive points but also highlights some concerns regarding soil fertility. Agricultural soils do not show a measurable change in their acidity, thus indicating an efficient management of pH at a national level. On the other hand, the report shows relatively low phosphorus levels for numerous soils, and inversely situations of structural excess which remain very worrying due to its impact on water quality and on the eutrophication of the environments. It also raises the questionsof the long-term sustainability of current cultivation systems and of a better treatment of effluents from livestock farming. Numerous situations also seem to be incompatible, for certain oligo-elements, with demanding cultures. At last, a major concern is the development of soil sealing, which has accelerated over the last decade and is responsible for the loss of large areas of agricultural soils

    Cabozantinib Versus Mitoxantrone-prednisone in Symptomatic Metastatic Castration-resistant Prostate Cancer: A Randomized Phase 3 Trial with a Primary Pain Endpoint

    Get PDF
    Background: Bone metastases in patients with metastatic castration-resistant prostate cancer (mCRPC) are associated with debilitating pain and functional compromise. Objective: To compare pain palliation as the primary endpoint for cabozantinib versus mitoxantrone-prednisone in men with mCRPC and symptomatic bone metastases using patient-reported outcome measures. Design, setting, and participants: A randomized, double-blind phase 3 trial (COMET-2; NCT01522443) in men with mCRPC and narcotic-dependent pain from bone metastases who had progressed after treatment with docetaxel and either abiraterone or enzalutamide. Intervention: Cabozantinib 60 mg once daily orally versus mitoxantrone 12 mg/m2 every 3 wk plus prednisone 5 mg twice daily orally. Outcome measurements and statistical analysis: The primary endpoint was pain response at week 6 confirmed at week 12 (≄30% decrease from baseline in patient-reported average daily worst pain score via the Brief Pain Inventory without increased narcotic use). The planned sample size was 246 to achieve ≄90% power. Results and limitations: Enrollment was terminated early because cabozantinib did not demonstrate any survival benefit in the companion COMET-1 trial. At study closure, 119 participants were randomized (cabozantinib: N =61; mitoxantrone-prednisone: N = 58). Complete pain and narcotic use data were available at baseline, week 6, and week 12 for 73/106 (69%) patients. There was no significant difference in the pain response with cabozantinib versus mitoxantrone-prednisone: the proportions of responders were 15%versus 17%,a −2%difference(95%confidenceinterval:−16%to11%, p = 0.8). Barriers to accrual included pretreatment requirements for a washout period of prior anticancer therapy and a narcotic optimization period to maximize analgesic dosing. Conclusions: Cabozantinib treatment did not demonstrate better pain palliation than mitoxantrone-prednisone in heavily pretreated patients with mCRPC and symptomatic bone metastases. Future pain-palliation trials should incorporate briefer timelines from enrollment to treatment initiation. Patient summary: Cabozantinib was not better than mitoxantrone-prednisone for pain relief in patients with castration-resistant prostate cancer and debilitating pain from bone metastases

    Ribosomal protein gene RPL9 variants can differentially impair ribosome function and cellular metabolism

    Get PDF
    Variants in ribosomal protein (RP) genes drive Diamond-Blackfan anemia (DBA), a bone marrow failure syndrome that can also predispose individuals to cancer. Inherited and sporadic RP gene variants are also linked to a variety of phenotypes, including malignancy, in individuals with no anemia. Here we report an individual diagnosed with DBA carrying a variant in the 5'UTR of RPL9 (uL6). Additionally, we report two individuals from a family with multiple cancer incidences carrying a RPL9 missense variant. Analysis of cells from these individuals reveals that despite the variants both driving pre-rRNA processing defects and 80S monosome reduction, the downstream effects are remarkably different. Cells carrying the 5'UTR variant stabilize TP53 and impair the growth and differentiation of erythroid cells. In contrast, ribosomes incorporating the missense variant erroneously read through UAG and UGA stop codons of mRNAs. Metabolic profiles of cells carrying the 5'UTR variant reveal an increased metabolism of amino acids and a switch from glycolysis to gluconeogenesis while those of cells carrying the missense variant reveal a depletion of nucleotide pools. These findings indicate that variants in the same RP gene can drive similar ribosome biogenesis defects yet still have markedly different downstream consequences and clinical impacts

    Cellobiose Dehydrogenase Aryl Diazonium Modified Single Walled Carbon Nanotubes: Enhanced Direct Electron Transfer through a Positively Charged Surface

    Get PDF
    One of the challenges in the field of biosensors and biofuel cells is to establish a highly efficient electron transfer rate between the active site of redox enzymes and electrodes to fully access the catalytic potential of the biocatalyst and achieve high current densities. We report on very efficient direct electron transfer (DET) between cellobiose dehydrogenase (CDH) from Phanerochaete sordida (PsCDH) and surface modified single walled carbon nanotubes (SWCNT). Sonicated SWCNTs were adsorbed on the top of glassy carbon electrodes and modified with aryl diazonium salts generated in situ from p-aminobenzoic acid and p-phenylenediamine, thus featuring at acidic pH (3.5 and 4.5) negative or positive surface charges. After adsorption of PsCDH, both electrode types showed excellent long-term stability and very efficient DET. The modified electrode presenting p-aminophenyl groups produced a DET current density of 500,mu A cm(-2) at 200 mV vs normal hydrogen reference electrode (NHE) in a 5 mM lactose solution buffered at pH 3.5. This is the highest reported DET value so far using a CDH modified electrode and comes close to electrodes using mediated electron transfer. Moreover, the onset of the electrocatalytic current for lactose oxidation started at 70 mV vs NHE, a potential which is 50 mV lower compared to when unmodified SWCNTs were used. This effect potentially reduces the interference by oxidizable matrix components in biosensors and increases the open circuit potential in biofuel cells. The stability of the electrode was greatly increased compared with unmodified but cross-linked SWCNTs electrodes and lost only 15% of the initial current after 50 h of constant potential scanning

    The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry

    Get PDF
    Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in Europe. Data from real-world registries are necessary, as clinical trials do not represent the full spectrum of VTE patients seen in clinical practice. We aimed to document the epidemiology, management and outcomes of VTE using data from a large, observational database. PREFER in VTE was an international, non-interventional disease registry conducted between January 2013 and July 2015 in primary and secondary care across seven European countries. Consecutive patients with acute VTE were documented and followed up over 12 months. PREFER in VTE included 3,455 patients with a mean age of 60.8 ± 17.0 years. Overall, 53.0 % were male. The majority of patients were assessed in the hospital setting as inpatients or outpatients (78.5 %). The diagnosis was deep-vein thrombosis (DVT) in 59.5 % and pulmonary embolism (PE) in 40.5 %. The most common comorbidities were the various types of cardiovascular disease (excluding hypertension; 45.5 %), hypertension (42.3 %) and dyslipidaemia (21.1 %). Following the index VTE, a large proportion of patients received initial therapy with heparin (73.2 %), almost half received a vitamin K antagonist (48.7 %) and nearly a quarter received a DOAC (24.5 %). Almost a quarter of all presentations were for recurrent VTE, with >80 % of previous episodes having occurred more than 12 months prior to baseline. In conclusion, PREFER in VTE has provided contemporary insights into VTE patients and their real-world management, including their baseline characteristics, risk factors, disease history, symptoms and signs, initial therapy and outcomes
    • 

    corecore